-
-
-
-
-
-
-
Select Sands Appoints Mr. Daniel Gillett and Mr. Steven Goldman to the Board of Directors
-
-
-
-
-
-
-
Aralez To Ring Closing Bell At Nasdaq On February 14, 2017
-
-
-
-
-
-
-
Aralez Provides Update on PBM Formulary Status for Yosprala
-
-
-
-
-
-
-
Aralez Pharma (ARLZ) to Acquire Toprol-XL U.S. Rights from AstraZeneca (AZN)
-
-
-
-
-
-
-
Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers
-
-
-
-
-
-
-
Aralez Pharma's (ARLZ) BLEXTEN Approved in Canada as SAR, CSU Treatment
-
-
-
-
-
-
-
Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA™
-
1,158,058 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

